- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Questar to open centers in Kansas City
Questar Imaging of Tampa, FL, is planning to establish two open MRI facilities in the Kansas City, MO, area in a joint venture with Magnetic Imaging, a subsidiary of Health Midwest of Kansas City. The facilities will be part of Questar's OpenScan MRI
Questar Imaging of Tampa, FL, is planning to establish two open MRI facilities in the Kansas City, MO, area in a joint venture with Magnetic Imaging, a subsidiary of Health Midwest of Kansas City. The facilities will be part of Questar's OpenScan MRI network, which provides open MRI services to hospitals as an adjunct to existing hospital services (SCAN 9/25/96). The centers are scheduled to be in operation by the middle of this year.
Questar has established seven OpenScan centers in the U.S., with three more (including the Kansas City sites) scheduled to go online this year. Questar is also in negotiations with partners to establish another seven OpenScan sites.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
